Autoimmune liver diseases (ALDs), including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC), are complex conditions involving the liver's immune ...

Autoimmune hepatitis (AIH) is a complex, chronic inflammatory liver disorder in which the body's immune system aberrantly targets hepatocytes, leading to progressive hepatic injury. Characterised by ...

The principle of therapy for chronic inflammatory liver diseases is the removal of causal agents. For autoimmune liver diseases, however, total removal of causal agents and immune cells is impossible.

Autoimmune hepatitis quietly damages the liver for years before symptoms appear; specialists in Kenya warn of late diagnoses and urge early medical checks. [File, Standard] When people think about ...

Cholestatic liver diseases and autoimmune hepatitis represent complex, immune‐mediated conditions that culminate in progressive hepatic injury. Disorders such as primary sclerosing cholangitis, ...

The prevalence of AILD and IBD supports the gut-liver axis theory. Inflammatory bowel disease (IBD) and autoimmune liver disease (AILD) prevalence are significantly correlated, according to a study in ...

A new drug to control liver disease has gotten the green light. The U.S. Food and Drug Administration (FDA) has approved the French drugmaker Ipsen’s medication Iqirvo (elafibranor). The drug, an 80 ...

Patients with autoimmune liver diseases reported non-adherence to prescribed therapies, with those with autoimmune hepatitis (AIH) reporting the highest rate of non‐adherence. The use of ...

Blood tests can help with the diagnosis of autoimmune hepatitis. These include tests for increased liver enzymes or antibody levels. However, other tests are necessary to confirm the diagnosis.